Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
Если иногда вам кажется, что жизнь настолько невыносима, что жить дальше бессмысленно, внимательно прочитайте этот материал.
Accessed on 2019
Preliminary version for country introduction
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
First WHO Global Ministerial Conference
Ending TB in the Sustainable Development Era: A Multisectoral Response
Moscow, Russian Federation, 16-17 November 2017
First WHO Global Ministerial Conference
Ending TB in the Sustainable Development Era: A Multisectoral Response
Moscow, Russian Federation, 16-17 November 2017
Первая глобальная министерская конференция ВОЗ
Ликвидировать туберкуле... в эпоху устойчивого развития: многосекторальный подход
Москва, Российская Федерация, 16-17 ноября 2017 г.
МОСКОВСКАЯ ДЕКЛАРАЦИЯ ПО ЛИКВИДАЦИИ ТУБЕРКУЛЕЗА
more
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
Médicaments et dispositifs médicaux pour une population de
10 000 personnes pendant environ 3 mois
Children's Health and the Environment WHO Training Package for the Health Sector World Health Organization